Premium
Bisphosphonate‐related osteonecrosis of the jaws: a comprehensive review
Author(s) -
Hewitt Catherine,
Farah Camile S.
Publication year - 2007
Publication title -
journal of oral pathology and medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.887
H-Index - 83
eISSN - 1600-0714
pISSN - 0904-2512
DOI - 10.1111/j.1600-0714.2007.00540.x
Subject(s) - medicine , bisphosphonate , osteonecrosis of the jaw , presentation (obstetrics) , oral hygiene , intensive care medicine , bone density conservation agents , bisphosphonate associated osteonecrosis of the jaw , dentistry , surgery , osteoporosis , pathology , bone density
Background: Bisphosphonate‐related osteonecrosis of the jaws (BRONJ) presents the clinician with significant management dilemmas. The purpose of this study was to distil information related to this disorder by comprehensively reviewing the literature. Methods: The structure and function of bisphosphonates, and their role in the development of BRONJ will be discussed, as will the possible mechanisms through which this pathology develops. A review of cases presented in the literature will be undertaken, and suggestions offered as to the management of this pathology in terms of surgical and conservative approaches. Results: Presentation of BRONJ is currently more common in patients taking intravenous forms of bisphosphonates, but there is a fear that the long‐term cumulative effects of oral bisphosphonates may see BRONJ increasingly occurring in this patient group. Conclusions: Prevention is superior to treatment, and the establishment of meticulous oral hygiene and pre‐emptive surgical treatment prior to commencement of bisphosphonate therapy is recommended.